Summary:

- The article reports on a study that investigated the use of a novel gene editing technology called "Casper" to treat a rare genetic disorder called Duchenne muscular dystrophy (DMD) in mice.
- The researchers were able to successfully correct the genetic mutation responsible for DMD in mouse models, leading to improved muscle function and reduced disease progression.
- The findings suggest that the Casper gene editing approach could be a promising therapeutic strategy for treating DMD and potentially other genetic disorders, though further research and clinical trials are needed to evaluate its safety and efficacy in humans.